Global Intravenous Immunoglobulin Market Share

Statistics for the 2023 & 2024 Global Intravenous Immunoglobulin market share, created by Mordor Intelligence™ Industry Reports. Global Intravenous Immunoglobulin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Intravenous Immunoglobulin Industry

The intravenous immunoglobulin market is moderately competitive, and vital global players manufacture most of the intravenous immunoglobulin therapies. Market leaders with more funds for research and a better distribution system have established their positions in the market. The key players in the studied market are Grifols SA, Takeda Pharmaceutical Company Limited, Biotest AG, Bio Products Laboratory Limited, and Kedrion SpA, among others. The major players are involved in strategies such as acquisitions, collaborations, and new product launches to secure their positions in the global market.

Intravenous Immunoglobulin (IVIG) Market Leaders

  1. Biotest AG

  2. Kedrion S.p.A

  3. Grifols, S.A.

  4. Bio Products Laboratory Limited

  5. Takeda Pharmaceutical Company Limited

*Disclaimer: Major Players sorted in no particular order

Intravenous Immunoglobulin Market Concentration

Intravenous Immunoglobulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)